Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis

Inclusion Criteria * Age: ≥ 18 years old * Gender: Male and Female * Patient who never uses or has stopped using topical corticosteroids/calcineurin inhibitor or other topical treatments exerting anti-inflammatory action (on the face) more than 2 weeks before entering this clinical trials. * Patient who does not use cosmetic containing any oxidants or others that exert anti-oxidant effect(s). If there is any, one must refrain from using them more than 2 weeks before entering this clinical trials. Exclusion Criteria * Patients with known cases of underlying HIV/AIDS, neurological condition e.g., Parkinson's disease. * Patient associated with any autoimmune diseases and other skin diseases * Patient takes any forms of oral immunotherapy more than 2 months up to the first day of clinical trials. * Patients continuously use of topical corticosteroids or other anti-inflammatory medicines on regular basis up to the first day of clinical trial. * Patient who refuses to stop using cosmetic(s) containing anti-oxidants or those exert anti-oxidant effect(s). * Patient who is allergic to the test product or one of its ingredients. * Pregnancy or nursing woman